APA

Akhondzadeh S., Shafiee Sabet M., Harirchian M. H., Togha M., Cheraghmakani H., Razeghi S., Hejazi S. S., Yousefi M. H., Alimardani R., Jamshidi A., Rezazadeh S., Yousefi A., Zare F., Moradi A. & Vossoughi A. (20100318). A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease. : Psychopharmacology.

Chicago

Akhondzadeh Shahin, Shafiee Sabet Mehdi, Harirchian Mohammad Hossein, Togha Mansoreh, Cheraghmakani Hamed, Razeghi Soodeh, Hejazi Seyyed Shamssedin, Yousefi Mohammad Hossein, Alimardani Roozbeh, Jamshidi Amirhossein, Rezazadeh Shams-Ali, Yousefi Aboulghasem, Zare Farhad, Moradi Atbin and Vossoughi Ardalan. 20100318. A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease. : Psychopharmacology.

Harvard

Akhondzadeh S., Shafiee Sabet M., Harirchian M. H., Togha M., Cheraghmakani H., Razeghi S., Hejazi S. S., Yousefi M. H., Alimardani R., Jamshidi A., Rezazadeh S., Yousefi A., Zare F., Moradi A. and Vossoughi A. (20100318). A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease. : Psychopharmacology.

MLA

Akhondzadeh Shahin, Shafiee Sabet Mehdi, Harirchian Mohammad Hossein, Togha Mansoreh, Cheraghmakani Hamed, Razeghi Soodeh, Hejazi Seyyed Shamssedin, Yousefi Mohammad Hossein, Alimardani Roozbeh, Jamshidi Amirhossein, Rezazadeh Shams-Ali, Yousefi Aboulghasem, Zare Farhad, Moradi Atbin and Vossoughi Ardalan. A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease. : Psychopharmacology. 20100318.